Read the findings & sources
Preclinical evidenceExperiments in macrophages found that hexarelin affected CD36-related signaling and cholesterol export. A related mouse model showed changes in atherosclerotic lesions. These mechanistic findings explain cardiovascular research interest, but they do not establish prevention of heart attacks, treatment of heart disease or a general fitness benefit in humans.

